VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3165
ETF rank
ยฃ11.79 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ15.93
Share price
-0.28%
Change (1 day)
-2.67%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of February 2026: 0.35%